Menu

Experience

Phillip McGill

    • Origin to List on Nasdaq via SPAC Merger With Artius 


    • Castle Biosciences $74 Million IPO 


    • Atlassian - $531 Million IPO 


    • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 


    • Cidara Completes Initial Public Offering  


    • Horizon Pharma Completes $400 Million Exchangeable Senior Notes Offering 


    • Bellicum Pharmaceuticals $160 million IPO 


    • Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes 


    • Ionis Pharmaceuticals Completes Rule 144A Offering $500 Million of Convertible Senior Notes 


    • Measurabl Series A and Series B Financings 


    • Bionano Genomics Initial Public Offering